Clinical and epidemiological correlates of low IFN-gamma responses in mitogen tube of QuantiFERON assay in tuberculosis infection screening during the COVID-19 …
JJ Palacios-Gutiérrez, A Rodríguez-Guardado… - Archivos de …, 2022 - Elsevier
Background The clinical and epidemiological implications of abnormal immune responses
in COVID-19 for latent tuberculosis infection (LTBI) screening are unclear. Methods We …
in COVID-19 for latent tuberculosis infection (LTBI) screening are unclear. Methods We …
Mice infected with Mycobacterium tuberculosis are resistant to acute disease caused by secondary infection with SARS-CoV-2
Mycobacterium tuberculosis (Mtb) and SARS-CoV-2 (CoV2) are the leading causes of death
due to infectious disease. Although Mtb and CoV2 both cause serious and sometimes fatal …
due to infectious disease. Although Mtb and CoV2 both cause serious and sometimes fatal …
Prevalence of indeterminate tuberculosis interferon‐gamma release assays in COVID‐19 patients: Systematic review and meta‐analysis
A Ben Tekaya, A Jerbi, M Ben Sassi… - Health Science …, 2023 - Wiley Online Library
Abstract Background and Aims The reliability of interferon‐gamma‐release‐assays (IGRAs)
for tuberculosis (TB) testing in coronavirus disease 2019 (COVID‐19) patients is unknown …
for tuberculosis (TB) testing in coronavirus disease 2019 (COVID‐19) patients is unknown …
The Impact of Viral and Bacterial Co-Infections and Home Antibiotic Treatment in SARS-CoV-2 Hospitalized Patients at the Policlinico Tor Vergata Hospital, Rome …
A Di Lorenzo, L Campogiani, M Iannetta, R Iannazzo… - Antibiotics, 2023 - mdpi.com
Co-infections during COVID-19 may worsen patients' outcomes. This study reports the
results of a screening assessing the presence of co-infections among patients hospitalized …
results of a screening assessing the presence of co-infections among patients hospitalized …
In patients with severe COVID-19, the profound decrease in the peripheral blood T-cell subsets is correlated with an increase of QuantiFERON-TB Gold Plus …
A Imeneo, G Alessio, A Di Lorenzo, L Campogiani… - Life, 2022 - mdpi.com
Increased rates of indeterminate QuantiFERON-TB Gold Plus Assay (QFT-Plus) were
demonstrated in patients hospitalized with Coronavirus Disease (COVID)-19. We aimed to …
demonstrated in patients hospitalized with Coronavirus Disease (COVID)-19. We aimed to …
IGRA test for TB in COVID-19: role of corticosteroids
B Granozzi, F Bisognin, M Tadolini… - … of Tuberculosis and …, 2022 - ingentaconnect.com
Dear Editor, Although the interaction between TB and COVID-19 is unclear, recent evidence
suggests that COVID-19 could worsen the outcome of active pulmonary TB or aggravate …
suggests that COVID-19 could worsen the outcome of active pulmonary TB or aggravate …
Longitudinal evaluation of the quantiFERON-TB Gold Plus assay in hospitalized COVID-19 patients with a first indeterminate result: resolution of inflammation and …
G Alessio, A Imeneo, A Di Lorenzo, B Rossi… - Microbiology …, 2022 - Am Soc Microbiol
(QFT-P) results in patients hospitalized because of severe Coronavirus Disease (COVID)-
19, and this is due to peripheral blood T-lymphocyte depletion and dysfunction (1-6), which …
19, and this is due to peripheral blood T-lymphocyte depletion and dysfunction (1-6), which …
The Relationship between Pre‐Pandemic Interferon Gamma Release Assay Test Results and COVID‐19 Infection: Potential Prognostic Value of Indeterminate IFN‐γ …
S Borekci, FG Karakas, S Sirekbasan… - Canadian Journal of …, 2021 - Wiley Online Library
Objective. To reveal the relationship between interferon‐gamma release assay (IGRA) test
(Standard ETB‐Feron ELISA (TBF)) results performed within 12 months before the COVID …
(Standard ETB‐Feron ELISA (TBF)) results performed within 12 months before the COVID …
[HTML][HTML] The Pitfalls of Mining for QuantiFERON Gold in Severely Ill Patients With COVID-19
MP Cortes, CS Schultz, S Isha, JE Sinclair… - … : Innovations, Quality & …, 2022 - Elsevier
Objective To assess the proportion of indeterminate QuantiFERON-TB Gold Plus (QFT-Plus)
results in patients admitted for severe coronavirus disease 2019 (COVID-19) pneumonia …
results in patients admitted for severe coronavirus disease 2019 (COVID-19) pneumonia …
Elevated rates of indeterminate results on quantiFERON-TB Gold Plus in COVID-19 patients
KL Shier - Journal of Clinical Microbiology, 2021 - Am Soc Microbiol
Interferon gamma release assays are used to screen various patient populations for latent
tuberculosis infection. In this issue of the Journal of Clinical Microbiology, JD Ward, C …
tuberculosis infection. In this issue of the Journal of Clinical Microbiology, JD Ward, C …